KDA Group Inc. (TSXV:KDA)

Canada · Delayed Price · Currency is CAD

0.1150

-0.0050 (-4.17%)

At close: Apr 27, 2026

Revenue by Segment

Financials in millions CAD. Fiscal year is August - July.

Millions CAD. Fiscal year is Aug - Jul.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021	Jul '20 Jul 31, 2020	Jul '19 Jul 31, 2019	Jul '18 Jul 31, 2018	Jul '17 Jul 31, 2017	Jul '16 Jul 31, 2016
Pharmaceutical Technology	96.00K	37.00K	95.00K	207.00K	-
Pharmaceutical Technology Growth	159.46%	-61.05%	-54.11%	-	-
Corporate and Others	69.00K	110.00K	66.00K	-	69.00K
Corporate and Others Growth	-37.27%	66.67%	-	-	16.62%
Pharmaceutical Solutions	-	-	-	-	11.14M
Pharmaceutical Solutions Growth	-	-	-	-	11.72%
Pharmacy Services	-	-	-	-	13.17M
Pharmacy Services Growth	-	-	-	-	2.32%
Total	165.00K	147.00K	161.00K	207.00K	24.37M
Total Growth	12.24%	-8.70%	-22.22%	-99.15%	6.45%

Revenue by Geography

Financials in millions CAD. Fiscal year is August - July.

Millions CAD. Fiscal year is Aug - Jul.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021	Jul '20 Jul 31, 2020	Jul '19 Jul 31, 2019	Jul '18 Jul 31, 2018	Jul '17 Jul 31, 2017	Jul '16 Jul 31, 2016
Canada	165.40K	147.42K	161.12K	207.09K	24.37M
Canada Growth	12.20%	-8.51%	-22.20%	-99.15%	6.45%
Total	165.40K	147.42K	161.12K	207.09K	24.37M
Total Growth	12.20%	-8.51%	-22.20%	-99.15%	6.45%

Source: S&P Global Market Intelligence.